LA
GMED icon

Legacy Advisors’s Globus Medical GMED Stock Holding History

Legacy Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$339K Buy
+4,628
New +$382K 0.03% 307

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Burgundy Asset Management
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Sculptor Capital
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Legacy Advisors's GMED Position: Q1 2025 in Review

Legacy Advisors opened a new position in Globus Medical (GMED) in Q1 2025: 4,628 shares worth $339K. The stake represents 0.03% of the portfolio and ranks #307 among its holdings.

516 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

  • Legacy Advisors held 4,628 shares of Globus Medical worth $339K as of Q1 2025.
  • Globus Medical was a new Legacy Advisors position in Q1 2025.
  • Globus Medical made up 0.03% of Legacy Advisors's portfolio in Q1 2025, its #307 holding.
  • 516 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Legacy Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.